SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. – SYRS
NEW YORK, Sept. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Syros Pharmaceuticals, Inc. (“Syros” or the “Company”) (NASDAQ: SYRS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Customers Bancorp, Inc. – CUBI
NEW YORK, Sept. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSE: CUBI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-58
Cainiao Doubles Down on Global Logistics Network with Launch of Second Batch of Global e-Hub Construction
Alibaba fully supports Cainiao to become a shared logistics infrastructure for all global customers.Cainiao launches the second batch of global eHub constructions. HANGZHOU, China, Sept. 10, 2024 /PRNewswire/ — Cainiao Group, a global leader in e-commerce logistics, today announced the launch
The Argentine Football Association Renews XTrend as National Team Sponsor in Europe
BARCELONA, Spain, Sept. 9, 2024 /PRNewswire/ — The Argentine Football Association (AFA) is pleased to announce the renewal of its partnership with XTrend as the Regional Sponsor of the Argentine National Team in Europe. This renewed agreement reinforces a successful collaboration that began la
L Catterton Acquires Majority Stake in Stenders
Stenders will leverage L Catterton’s expertise and network to accelerate its international expansion RIGA, Latvia, Sept. 9, 2024 /PRNewswire/ — L Catterton, a leading global consumer-focused investment firm, today announced that it has acquired a majority stake in Stenders, a premium bat
Ionis announces pricing of $500.3 million public offering
CARLSBAD, Calif., Sept. 9, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the pricing of an underwritten public offering of 11,500,000 shares of its common stock. The shares of common stock are being sold at a public offering price of $43.50 per share. The aggre
CenterPoint Energy is Taking Key Actions to Prepare and Respond To Impact of Tropical Storm Francine
CenterPoint is preparing staging sites, mobilizing crews and equipment, communicating safety and preparedness tips to its customers, and securing additional frontline resources from mutual assistance partners. CenterPoint Energy has activated the company’s Emergency Operations Center and is ex
Mountain & Co. I Acquisition Corp. Announces Receipt of Nasdaq Delisting Determination – Intention to Appeal
NEW YORK, Sept. 9, 2024 /PRNewswire/ — Mountain & Co. I Acquisition Corp. (the “Company”) announces that on September 3, 2024, the Company received a letter (the “Letter”) from the NASDAQ Stock Market (“Nasdaq”) notifying the Company that Nasdaq Listing
Hanwha Vision Reinforces Commitment to Excellence, Ethics, and Sustainability
Company recognized for global benchmark in compliance and risk managementGlobal standards and ESG drive Hanwha Vision’s reputation as a trusted partnerCertifications like ISO37301/27001/9001/14001/45001 and AEO demonstrate its global leadership SEONGNAM, South Korea, Sept. 10, 2024 /PRNewswire
Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation
SAN FRANCISCO and SUZHOU, China, Sept. 10, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabo
